Curve founder dey request 17.45M CRV (~$6.6M) grant to fund development
Curve founder Michael Egorov propose say make dem give Swiss Stake AG 17.45 million CRV (about $6.6M) grant to fund core protocol development, maintenance and ecosystem support till 2026. The proposal weh dem post for Curve DAO governance forum go extend earlier funding wey dem approve for late 2024 and fit keep 25-person dev team wey dey focus on software R&D, security, infrastructure, smart-contract maintenance, lending tech (including Llamalend V2), on-chain FX product (FXSwap), crvUSD and cross-chain integrations plus UI improvements. Under the grant, Swiss Stake AG fit stake unused CRV for liquid lockers (eg Convex, Yearn) to generate yield; tokens no fit chop for unrelated activities. Any IP wey dem produce go release under open-source license wey match Curve’s codebase. Swiss Stake AG go publish spending reports twice each year. Voting open till Dec 22, 2025, and early votes favor the proposal. At publication CRV get small intraday gains after bounce back from multi-week lows; the vote result fit affect DAO treasury allocations and CRV token dynamics. For traders: if dem approve e go secure dedicated developer capacity, likely support product roadmap execution and fit be mildly bullish for CRV medium-term by reducing execution risk and showing continued protocol investment, while rejection or delays fit increase uncertainty about development cadence and be negative catalyst.
Neutral
Di proposal secure funding for core development and maintenance, wey dey reduce execution risk and support roadmap delivery — things wey usually good for token fundamentals. The option to stake unused CRV for liquid lockers fit also generate yield and small reduce selling pressure if people keep the yields. Early favourable votes and small intraday price gains show say positive sentiment dey limited. But the grant no be immediate on‑chain economic event like token burns or buybacks; market impact go depend on DAO voting, implementation, and how transparent dem spend money. If dem approve am, the news likely mild bullish to neutral for CRV medium term because e go improve development continuity and product rollout prospects. If dem reject or delay am, uncertainty about development capacity fit be short‑term negative. So expected price impact no strong bullish or bearish immediately — traders suppose to watch voting outcomes, reported expenditures, and any CRV staking/locker flows for more direct price signals.